Treatment of vascular dementia—evidence from clinical trials with cholinesterase inhibitors
- 15 November 2004
- journal article
- review article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 226 (1-2) , 63-66
- https://doi.org/10.1016/j.jns.2004.09.018
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Efficacy and Tolerability of Donepezil in Vascular DementiaStroke, 2003
- Donepezil in vascular dementiaNeurology, 2003
- Cholinergic denervation in a pure multi-infarct stateNeurology, 2003
- Donepezil‐Treated Patients with Probable Vascular Dementia Demonstrate Cognitive BenefitsAnnals of the New York Academy of Sciences, 2002
- Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?International Journal of Geriatric Psychiatry, 2001
- Trajectories of cholinergic pathways within the cerebral hemispheres of the human brainBrain, 1998
- Neurochemical profiles in cerebrospinal fluid of stroke-prone spontaneously hypertensive ratsNeuroscience Letters, 1994
- Vascular dementiaNeurology, 1993
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- A comparative histochemical mapping of the distribution of butyryl cholinesterase in the brains of four species of mammals, including manCells Tissues Organs, 1967